Bleakley Financial Group, LLC Xeris Biopharma Holdings, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 10,536 shares of XERS stock, worth $61,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,536
Previous 11,116
5.22%
Holding current value
$61,214
Previous $31.7 Million
12.74%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$60 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$45.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$19.5 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$19.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$16.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $790M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...